drugset / Trial / NCT04101019

Sphenopalatine Ganglion Block to Treat Shoulder Pain After Laparoscopic Surgery

NCT04101019 ↗

Unknown 76 enrolled Rabin Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a prospective double blinded randomized pilot trial to evaluate the efficacy of phenopalatine ganglion block (SPGB) block to manage shoulder tip pain (STP) after laparoscopic surgery. Patients undergoing laparoscopic surgery will be approached by a member of the research team and those found eligible for participating will be enrolled after signing an informed consent form. Patients will be randomized to have the SPGB block with saline versus active drug which contains 10% lidocaine diluted to 5%. The block will be performed , by an experienced member of the research team, and the patient will then be followed up by the investigator for any adverse events and levels of shoulder pain.

Timeline

Start
2019-09
Primary completion
2020-09
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 1.5 ml Intranasal
Comparator Lidocaine Other / unclassified 5 % Intranasal